U.K. Trade Distributors Stock News

LSE:CBG
LSE:CBGBanks

3 UK Financial Stocks Exposed To Deregulation Including Close Brothers Stock

Money talks in politics and the latest £72mn wave of donations to Reform UK has turned the volume up on potential deregulation and pro growth policies that could reshape parts of the UK market. If rules, taxes or red tape tilt even slightly, some UK listed stocks wired into the domestic economy could feel it most. This article walks through three such companies from our screener that look especially exposed to that shift, for better or worse. The three stocks below are just a starting sample...
LSE:REL
LSE:RELProfessional Services

RELX (LSE:REL) Stock Looks Cheap Relative To Fair Value

RELX has had a rough patch over the past year, yet the current share price still screens as cheap on both cash flow estimates and traditional valuation checks. That split between a weak recent share performance and an intrinsic value estimate that points to a discount is what investors now need to weigh. Over the past 12 months, RELX shares have fallen 26.1%, which puts recent sentiment and price momentum firmly on the back foot. Reliable recurring revenue and cash generation from RELX's...
LSE:SHEL
LSE:SHELOil and Gas

Shell (LSE:SHEL) Stock Still Looks Reasonable After 196% Return And 23% Fair Value Gap

Shell stock has produced a strong 5 year gain while current valuation checks still lean cheap, with both an intrinsic value estimate from a Discounted Cash Flow (DCF) approach and market multiples pointing to upside relative to the recent share price. That mix of a long run share price climb and an undervalued read from several models is drawing attention to how much good news from recent deals and higher oil prices is already reflected in Shell’s valuation. Over the past 5 years Shell has...
LSE:STAN
LSE:STANBanks

3 Financial Stocks Worth Watching As Higher Rates Lift Bank And Insurer Earnings

Central banks are turning more hawkish at the same time energy prices stay stubbornly high, and that mix is quietly rewiring how money flows through global markets. Higher policy rates can punish stretched valuations, yet they also reshape what banks and insurers earn on loans and investment portfolios. This article unpacks that story and profiles 3 stocks from our Global Banks and Insurers Benefiting from Higher Interest Rates screener that appear particularly exposed to this new rate...
LSE:BP.
LSE:BP.Oil and Gas

BP (LSE:BP.) Has A Fresh Development, But What Should Investors Make Of It?

BP (LSE:BP.) has kicked off a fresh chapter in its boardroom by appointing Ian Tyler as chairman, following Albert Manifold’s removal over conduct and governance concerns earlier this year. BP’s latest governance shake up comes after a strong run in the stock, with a year to date share price return of 28.93% and a 1 year total shareholder return of 41.19%, suggesting that momentum has been building rather than fading. Scan how BP’s boardroom reset compares with other large energy players by...
LSE:FSJ
LSE:FSJInfrastructure

3 Oil Transport Stocks Retail Investors Are Watching After Oil Hit $100

Oil prices above US$100, diesel near US$6 a gallon and talk of Venezuelan output returning in size have pushed midstream pipes and tanker routes back into the spotlight. Cash is flowing through the system, not just at the wellhead. Miss how that reshapes fee income and freight demand and you risk sitting out a powerful move. This article walks through three stocks from the screener that appear closely aligned with this news shock and explains where their exposure could matter most for your...
LSE:HSBA
LSE:HSBABanks

HSBC (LSE:HSBA) Stock Looks Cheap On Fair Value But Pricey On Earnings

HSBC Holdings has delivered a very large 5 year gain for shareholders, yet its current valuation picture is split, with the Excess Returns intrinsic value estimate pointing to upside while market based multiples lean the other way. Over the past 5 years, HSBC Holdings has returned about 4.6x. This puts recent debate firmly on whether the current share price already embeds very optimistic expectations. Recent leadership changes, including CFO Pam Kaur planning to step down while remaining as...
LSE:AZN
LSE:AZNPharmaceuticals

AstraZeneca (LSE:AZN) Trial Wins Keep Valuation In Focus As Shares Drift

AstraZeneca (LSE:AZN) has been back in the spotlight after new Phase III data for lung cancer drug IMFINZI and COPD biologic tozorakimab, as well as fresh approvals in breast cancer and HER2 positive disease. The recent IMFINZI and tozorakimab updates slot into a busy few weeks for AstraZeneca, yet the share price has drifted. The 90-day share price return is 13.03% and the year-to-date share price return is 13.86%, while the 1-year total shareholder return is 0.97% and the 5-year total...
LSE:RR.
LSE:RR.Aerospace & Defense

Rolls Royce (LSE:RR.) Stock Could Be 21% Overvalued Despite Indiana Expansion

Rolls-Royce Holdings has delivered a very large 5 year gain that now meets a less generous valuation read, with the Discounted Cash Flow (DCF) estimate pointing to the shares trading at a premium while market based multiples look roughly in line and the broader value score leans expensive. The stock is up very sharply over 5 years, which means a lot of optimism is already reflected in the current share price. The completed US$1b investment in the Indiana manufacturing campus, together with...
AIM:AOM
AIM:AOMSoftware

UK Penny Stocks With Market Caps Over £50M To Watch

The UK market has recently faced challenges, with the FTSE 100 index slipping due to weak trade data from China, highlighting global economic interdependencies. Despite these broader market pressures, there are opportunities within specific segments of the stock market. Penny stocks, though an older term, still represent smaller or newer companies that can offer significant value when backed by strong financials and growth potential.
LSE:GSK
LSE:GSKPharmaceuticals

GSK (LSE:GSK) Stock Could Be Below Fair Value Following mRNA Flu Vaccine Progress

GSK stock has delivered a roughly 54.5% total return over the past 5 years, yet recent weakness and a high value score suggest the market may still be pricing the pharmaceutical group cautiously. Investors now have to reconcile a solid longer term track record with a share price that screens as cheap on broader valuation checks. Around 54.5% total return over 5 years points to meaningful long run value creation for holders who stayed invested. Progress on cancer therapies and an mRNA flu...
LSE:KNOS
LSE:KNOSIT

3 UK AI Stocks Investors Are Screening After The GDP Surprise

UK GDP surprising to the upside in July and a sharp pickup in IT and AI-related services has put a fresh spotlight on UK-listed AI and IT services stocks. Stronger activity can help well-positioned companies, while higher bond yields and rate worries still keep pressure on the market. This article walks through three stocks exposed to these forces and explains how the same news can create opportunity or risk for your portfolio. The three stocks below are a small sample of what UK-listed AI...
LSE:SHEL
LSE:SHELOil and Gas

Shell (LSE:SHEL) Recasts US Power With Rhode Island Exit And Pennsylvania Move

Shell (LSE:SHEL) has agreed to sell a gas-fired power plant in Rhode Island as it reshapes its US power operations. The group is acquiring a flexible power generation asset in Pennsylvania, expanding its footprint in the PJM wholesale electricity market. Together, the two transactions mark a shift toward asset backed power trading in the largest US competitive power region. Shell's Rhode Island exit and Pennsylvania purchase matter, but investors should weigh them against the wider Shell...
LSE:BARC
LSE:BARCBanks

Barclays (LSE:BARC) Stock May Trade At A Discount On Fresh Financing News

Barclays has delivered a very strong 3 year run, yet its current valuation checks point to a stock that still screens cheap on most fundamental measures. The Excess Returns intrinsic value estimate suggests the shares trade at a steep discount to what the model implies, while market multiples look broadly in line with peers. Over the past 3 years, Barclays has returned about 232.4%, which puts recent weakness into context and raises the question of how much of that gain is now backed by...
AIM:THRU
AIM:THRUElectronic

3 Promising UK Penny Stocks With Over £10M Market Cap

The UK stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines due to weak trade data from China impacting global economic sentiment. Despite these broader market fluctuations, there remain opportunities for investors willing to explore lesser-known segments of the market. Penny stocks, while an outdated term, still represent a valuable area for investment; they often involve smaller or newer companies that can offer growth potential when...
AIM:AET
AIM:AETOil and Gas

Exploring 3 Undervalued Small Caps In The European Market With Insider Action

In recent weeks, the European market has faced pressure from rising energy prices and bond yields due to geopolitical tensions, but sentiment has stabilized as these factors moderated. Amidst this backdrop, investors are keenly observing small-cap stocks that might be positioned for growth, particularly those with insider activity suggesting potential undervaluation.
LSE:BP.
LSE:BP.Oil and Gas

BP (LSE:BP.) Stock Could Be 44% Undervalued After Windfall Tax Fears

BP has delivered a strong 5 year share price run, yet investors are getting mixed valuation messages as the Discounted Cash Flow (DCF) estimate points to a sizeable gap to intrinsic value while earnings based multiples screen the stock as expensive and the broader value score remains low. BP has returned 136.7% over 5 years, which puts recent pricing on the radar for investors who care about what they are paying versus what they are getting. Management moves to simplify BP into upstream and...
LSE:BEZ
LSE:BEZInsurance

3 Insurance Stocks Retail Investors Are Watching For Rising AI Liability Demand

AI safety alarms are getting louder, with OpenAI and Anthropic researchers pushing public worries about existential and cybersecurity risks into the political spotlight. That debate could reshape how risk is priced and who carries the bill. If you care about where AI liability, regulation and insurance collide, this is a moment to pay attention. This article walks through 3 stocks exposed to the latest headlines and why that might matter for your portfolio. The three stocks reviewed below are...